Escalon Medical Corp.: diluted weighted-average shares
Diluted weighted-average shares for Escalon Medical Corp. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Escalon Medical Corp. financial histories
What this measure means
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
Exact concept: us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-07-01 to 2025-06-30. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2024-07-01 | 2025-06-30 | 14,252,202 | shares | 2025-09-29 | 10-K · 0001628280-25-043095 |
| 2023-07-01 | 2024-06-30 | 7,415,329 | shares | 2025-09-29 | 10-K · 0001628280-25-043095 |
| 2022-07-01 | 2023-06-30 | 13,564,202 | shares | 2024-09-30 | 10-K · 0000862668-24-000022 |
| 2021-07-01 | 2022-06-30 | 13,220,202 | shares | 2023-10-13 | 10-K · 0000862668-23-000022 |
| 2020-07-01 | 2021-06-30 | 7,415,329 | shares | 2022-09-28 | 10-K · 0000862668-22-000023 |
| 2019-07-01 | 2020-06-30 | 7,415,329 | shares | 2021-09-27 | 10-K · 0000862668-21-000013 |
| 2018-07-01 | 2019-06-30 | 7,415,329 | shares | 2020-09-28 | 10-K · 0000862668-20-000008 |
| 2017-07-01 | 2018-06-30 | 9,141,468 | shares | 2019-09-27 | 10-K · 0000862668-19-000010 |
| 2016-07-01 | 2017-06-30 | 7,551,430 | shares | 2018-09-28 | 10-K · 0000862668-18-000014 |
| 2015-07-01 | 2016-06-30 | 7,541,013 | shares | 2017-09-28 | 10-K · 0000862668-17-000014 |
| 2014-07-01 | 2015-06-30 | 7,526,430 | shares | 2016-10-12 | 10-K · 0000862668-16-000043 |
| 2013-07-01 | 2014-06-30 | 7,526,430 | shares | 2015-09-29 | 10-K · 0000862668-15-000011 |
| 2012-07-01 | 2013-06-30 | 7,526,430 | shares | 2014-09-26 | 10-K · 0000862668-14-000007 |
| 2011-07-01 | 2012-06-30 | 7,526,430 | shares | 2013-09-20 | 10-K · 0000862668-13-000011 |
| 2010-07-01 | 2011-06-30 | 7,526,430 | shares | 2012-09-26 | 10-K · 0001445305-12-003000 |
Related financial histories
- Escalon Medical Corp.: total assets
- Escalon Medical Corp.: total liabilities
- Escalon Medical Corp.: stockholders equity
- Escalon Medical Corp.: cash and cash equivalents
- Escalon Medical Corp.: net income or loss
- Escalon Medical Corp.: operating cash flow
- Escalon Medical Corp.: capital expenditure payments
- Escalon Medical Corp.: revenue
- Escalon Medical Corp.: financing cash flow
- Escalon Medical Corp.: investing cash flow
- Escalon Medical Corp.: retained earnings or deficit
- Escalon Medical Corp.: basic weighted-average shares
- Escalon Medical Corp.: basic earnings per share
- Escalon Medical Corp.: diluted earnings per share
- Escalon Medical Corp.: income tax expense or benefit
- Escalon Medical Corp.: net property, plant and equipment
- Escalon Medical Corp.: operating income or loss
- Escalon Medical Corp.: current assets
- Escalon Medical Corp.: interest expense
- Escalon Medical Corp.: current liabilities
- Escalon Medical Corp.: current accounts payable
- Escalon Medical Corp.: goodwill carrying amount
- Escalon Medical Corp.: net finite-lived intangible assets
- Escalon Medical Corp.: net current accounts receivable
- Escalon Medical Corp.: net inventory
- Escalon Medical Corp.: selling, general and administrative expense
- Escalon Medical Corp.: research and development expense
Inspect the source
- Entity
- Escalon Medical Corp. / CIK 0000862668
- Captured
- 2026-09-20T04:59:43.148Z
- SEC response SHA-256
1553c3790334a15d4c4528d0e1ce16eac37d12130ed9cd66f6b338c07ce2533d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000862668.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))